'Big Pharma Is Changing Under Pressure'

On the 27th of May, 'De Volkskrant', a leading Dutch daily, reports on how pharmaceutical companies are challenged by the Access to Medicine Index to do more on access to medicine in the developing countries. Last week, May 24th, the 'Index' pharma companies gathered in Amstelveen (The Netherlands), to discuss the data collection process around the Index 2012. “Societal pressure for sustainable and social production is so high now, you have to deal with it as a company. Shareholders also want stable and sustainable results and are taking an ever increasing amount of interest in public opinion. In this context, the Index is a major driving force”, says Sophia Tickell (Chair of the 'Amstelveen' meeting and founder of the PharmaFutures-series), when talking about the power of the Index. Read more about what GSK and Pfizer are doing on access to medicine in the full article at 'Downloads'.